CNR Institutional Research Information System

DEL GATTO, ANNARITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.576
NA - Nord America 856
EU - Europa 370
SA - Sud America 292
AF - Africa 21
OC - Oceania 1
Totale 3.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 806
SG - Singapore 648
CN - Cina 398
BR - Brasile 236
VN - Vietnam 168
HK - Hong Kong 140
FR - Francia 111
IT - Italia 103
KR - Corea 76
JP - Giappone 36
IN - India 31
DE - Germania 29
CA - Canada 27
GB - Regno Unito 25
NL - Olanda 25
AR - Argentina 23
FI - Finlandia 22
BD - Bangladesh 21
MX - Messico 12
IL - Israele 11
CO - Colombia 9
ID - Indonesia 9
PL - Polonia 9
ZA - Sudafrica 9
SA - Arabia Saudita 8
ES - Italia 7
RU - Federazione Russa 7
CL - Cile 6
PY - Paraguay 6
TR - Turchia 6
GR - Grecia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
JM - Giamaica 4
KE - Kenya 4
UA - Ucraina 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
IQ - Iraq 3
NP - Nepal 3
PH - Filippine 3
SE - Svezia 3
AT - Austria 2
BO - Bolivia 2
GA - Gabon 2
IR - Iran 2
LT - Lituania 2
PT - Portogallo 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GP - Guadalupe 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KH - Cambogia 1
MA - Marocco 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.116
Salva come PNG Salva come JPEG
Città #
Singapore 377
Santa Clara 236
Hefei 158
Hong Kong 140
San Jose 113
Beijing 99
Lauterbourg 78
Seoul 76
Ashburn 70
Ho Chi Minh City 70
Dallas 44
Los Angeles 40
Tokyo 26
Hanoi 24
Naples 23
São Paulo 23
New York 17
Frankfurt am Main 16
Afragola 12
Casandrino 12
Helsinki 12
Buffalo 11
Rio de Janeiro 11
Minamishinagawa 10
Guangzhou 9
Lappeenranta 9
Montreal 9
Rome 9
Council Bluffs 8
Atlanta 7
Chennai 7
Thái Bình 7
Warsaw 7
Amsterdam 6
Curitiba 6
Da Nang 6
Haiphong 6
Belo Horizonte 5
Bengaluru 5
Boston 5
Guarulhos 5
Hải Dương 5
Jeddah 5
Manchester 5
Nuremberg 5
Orem 5
Porto Alegre 5
Salvador 5
Ankara 4
Athens 4
Can Tho 4
Denver 4
Ercolano 4
Houston 4
Miami 4
Nairobi 4
Pittsburgh 4
Poplar 4
Quận Một 4
Toronto 4
Turin 4
Aracaju 3
Auburn 3
Baltimore 3
Biên Hòa 3
Brasília 3
Brooklyn 3
Caxias do Sul 3
Charlotte 3
Chicago 3
Dayton 3
Düsseldorf 3
Elk Grove Village 3
Guwahati 3
Johannesburg 3
Juiz de Fora 3
London 3
Manaus 3
Marília 3
Mexico City 3
Milan 3
Munich 3
Osasco 3
Philadelphia 3
Phoenix 3
Prague 3
Riyadh 3
São Gonçalo 3
São José dos Campos 3
The Bronx 3
Volla 3
Anápolis 2
Apucarana 2
Araçatuba 2
Asunción 2
Baghdad 2
Barbacena 2
Bari 2
Boardman 2
Bogotá 2
Totale 2.009
Salva come PNG Salva come JPEG
Nome #
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 81
Peptoids: Smart and Emerging Candidates for the Diagnosis of Cancer, Neurological and Autoimmune Disorders 79
Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications 78
18FLUORO-ACTIVE PEPITDES.: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 75
Molecular interactions between a diphenyl scaffold and PED/PEA15: Implications for type II diabetes therapeutics targeting PED/PEA15 - Phospholipase D1 interaction 71
Conformational studies of RGDechi peptide by natural-abundance NMR spectroscopy 70
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 ?-like: from in silico identification to experimental evidence 67
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 64
A multi-targeting approach to fight sars-cov-2 attachment 64
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 61
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 58
An overview of peptide-based molecules as potential drug candidates for multiple sclerosis 58
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development 57
A selective ?v?5 integrin antagonist hidden into the anophelin family protein cE5 from the malaria vector anopheles gambiae 56
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 55
A novel approach for studying receptor-ligand interactions on living cells surface by using NUS/T1ρ-NMR methodologies combined with computational techniques: The RGDechi15D-αvβ5 integrin complex 55
High-Resolution Conformational Analysis of RGDechi-Derived Peptides Based on a Combination of NMR Spectroscopy and MD Simulations 55
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 54
Investigation of the Best Conditions to Obtain c(RGDfK) Peptide on Solid Phase 53
Peptides Targeting Angiogenesis Related Growth Factor Receptors 52
Morphological, productive and energetic characterization of Brassica carinata in Central, North and South Areas of Italy 48
Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting. 48
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 47
Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments 47
Selective Targeting of alphavbeta5 Integrin in HepG2 Cell Line by RGDechi15D Peptide 45
On-Bead Peptoid Dimerization Induced by Incorporation of Glycosylated Bridging Units in Submonomer Solid-Phase Approach to Glycopeptoids 45
18FLUORO-ACTIVE-PEPTIDES: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 45
Evaluation of the anti-angiogenic properties of the new selective alpha(V)beta(3) integrin antagonist RGDechiHCit 44
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 41
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 41
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 40
Bioinspired RGD-Functionalized Gold Nanoparticles for Integrin-Driven Interaction with Melanoma Cells 40
Structural Zn(II) Implies a Switch from Fully Cooperative to Partly Downhill Folding in Highly Homologous Proteins 38
Conjugated Platinum(II)-peptide complexes for targeting integrin receptors 37
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 34
Structure-Based Design of a Potent Artificial Transactivation Domain Based on p53 34
HIGH YIELD HPLC PURIFICATION OF 18F-RDG-ECHI FOR INJECTION INTO MICE. 33
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 33
Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo 32
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 32
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 32
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 31
Insights into the anticancer properties of the first antimicrobial peptide from Archaea 31
Silver nanoparticles functionalized with a fluorescent cyclic RGD peptide: a versatile integrin targeting platform for cells and bacteria 30
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 30
Peptides reproducing the ApoA-I 141-164 region: Studies on Hpt recognition 29
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 28
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 28
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 28
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 28
A new and selective radiolabeled áVâ3 peptide antagonist as tracer in tumor diagnosis 28
Zinc to Cadmium Replacement in the A. thaliana SUPERMAN Cys(2)His(2) Zinc Finger Induces Structural Rearrangements of Typical DNA Base Determinant Positions. 28
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 28
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 28
P53/TFIIH complex: structure-guided design of peptides to modulate apoptosis mediated by p53-dependent pathways 27
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 27
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 27
Proangiogenic properties of QK, a peptide mimicking VEGF/KDR binding interface 27
Engineering peptides in angiogenesis 27
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 26
Development Of Peptides Able To Modulate The Interaction Of AKAP121 With Mitochondria 26
Selective avb3 receptor peptide antagonist for therapeutic and diagnostic applications 26
Helical peptide as VEGF antagonist 25
Targeting avb3 integrin receptor by a new and selective peptide antagonist 25
Peptide-based molecules in angiogenesis. 25
Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour 25
Deciphering rgdechi peptide??5?1integrin interaction mode in isolated cell membranes 24
BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 24
Design, synthesis and evaluation of gluten peptide analogues as inhibitors of the HLA/DQ8-mediated celiac immune response 24
Small helical peptides as modulator of angiogenesis 24
BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 23
Integrin receptor family: promising target for therapeutic and diagnostic applications 23
Preparation and Characterization of new functionalized gold nanoparticles 23
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 23
Structure-based design of short peptides and samll molecules that compete with P53 for binding to TFIIH 23
Inibizione dell angiogenesi mediante un antagonista selettivo dell integrina ±V²3 endoteliale: studi in vitro e in vivo 22
RGDechi-hCit: alpha v beta 3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells 22
Novel and Selective Ligand of the Integrin n Ñv Ò3 Receptor: Design, Synthesis and Biological Behaviour 21
Small helical peptides as modulator of angiogenesis 21
A Combined NMR and Computational Approach to Determine the RGDechi-hCit-alpha(v)beta(3) Integrin Recognition Mode in Isolated Cell Membranes 19
Development of new molecules that compete with p53 for Binding to TFIIH 19
SYNTHETIC PEPTIDES ABLE TO MODULATE THE INTERACTION OF AKAP121 WITH MITOCHONDRIA 19
Peptides for tumour therapy and diagnosis: current status and future directions 17
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 16
null 16
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress 11
Identification of the first peptide inhibitor of UBE2C enzymatic activity: insights from metadynamics-guided folding and binding studies 4
Totale 3.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.262
article - articoli 7.155
book - libri 95
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202448 0 0 0 0 0 0 0 0 11 4 24 9
2024/20251.163 4 5 124 48 226 24 33 57 41 48 309 244
2025/20261.918 116 232 163 333 362 70 264 86 87 123 43 39
2026/202776 76 0 0 0 0 0 0 0 0 0 0 0
Totale 3.205